EATON VANCE MANAGEMENT

Holdings History for AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO)

Symbol: AGIO on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2022	0%	-0%	$1,936,000	68,447	-6,525	-8.7%	$28.28	Q3 2022
30 Jun 2022	0%	0%	$1,662,000	74,972	-1	-0%	$22.17	Q2 2022
31 Mar 2022	0%	0%	$2,182,000	74,973	+1	+0%	$29.10	Q1 2022
31 Dec 2021	0%	0%	$2,464,000	74,972	0		$32.87	Q4 2021
30 Sep 2021	0%	0%	$3,460,000	74,972	0		$46.15	Q3 2021
30 Jun 2021	0.01%	-0%	$4,132,000	74,972	-627	-0.83%	$55.11	Q2 2021
31 Mar 2021	0.01%	+0%	$3,904,000	75,599	+507	+0.68%	$51.64	Q1 2021
31 Dec 2020	0.01%	0%	$3,254,000	75,092	0		$43.33	Q4 2020
30 Sep 2020	0%	0%	$2,628,000	75,092	0		$35.00	Q3 2020
30 Jun 2020	0.01%	-0%	$4,016,000	75,092	-25	-0.03%	$53.48	Q2 2020
31 Mar 2020	0.01%	0%	$2,665,000	75,117	0		$35.48	Q1 2020
31 Dec 2019	0.01%	+0%	$3,587,000	75,117	+76	+0.1%	$47.75	Q4 2019
30 Sep 2019	0.01%	-0%	$2,431,000	75,041	-58,879	-44%	$32.40	Q3 2019
30 Jun 2019	0.01%	-0%	$6,680,000	133,920	-33,550	-20%	$49.88	Q2 2019
31 Mar 2019	0.03%	+0.01%	$11,294,000	167,470	+50,738	+43%	$67.44	Q1 2019
31 Dec 2018	0.01%	+0%	$5,383,000	116,732	+10,484	+9.9%	$46.11	Q4 2018
30 Sep 2018	0.02%	0%	$8,194,000	106,248	0		$77.12	Q3 2018
30 Jun 2018	0.02%	+0%	$8,949,000	106,248	+20,092	+23%	$84.23	Q2 2018
31 Mar 2018	0.02%	-0%	$7,046,000	86,156	-12,465	-13%	$81.78	Q1 2018
31 Dec 2017	0.01%	+0.01%	$5,638,000	98,621	+43,741	+80%	$57.17	Q4 2017
30 Sep 2017	0.01%	0%	$3,663,000	54,880	0		$66.75	Q3 2017
30 Jun 2017	0.01%	0%	$2,824,000	54,880	0		$51.46	Q2 2017
31 Mar 2017	0.01%	0%	$3,205,000	54,880	0		$58.40	Q1 2017
31 Dec 2016	0.01%	0%	$2,290,000	54,880	0		$41.73	Q4 2016
30 Sep 2016	0.01%	0%	$2,899,000	54,880	0		$52.82	Q3 2016
30 Jun 2016	0.01%	0%	$2,299,000	54,880	0		$41.89	Q2 2016
31 Mar 2016	0.01%	0%	$2,228,000	54,880	0		$40.60	Q1 2016
31 Dec 2015	0.01%	0%	$3,563,000	54,880	0		$64.92	Q4 2015
30 Sep 2015	0.01%	+0.01%	$3,874,000	54,880	+54,880	NEW	$70.59	Q3 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.